Posted inBusiness
Dr. Reddy’s Delays Semaglutide Rollout Following Quality Control Concerns
Dr. Reddy's halts semaglutide launch due to quality concerns, impacting shares and the race for generic weight-loss and diabetes treatments.
Posted inHealth
Medicare Begins Coverage of GLP-1 Drugs for Weight Loss July 1: What to Know
Starting July 1, the federal government will initiate a restricted pilot program providing Medicare coverage for GLP-1 receptor agonists specifically for weight loss, marking a significant shift in how the…
Posted inHealth
Canada Approves First Generic Semaglutide for Weight Loss
Health Canada has officially authorized the first generic version of semaglutide specifically indicated for weight management, marking a significant shift in the accessibility of GLP-1 receptor agonists across the country.…
